UBE2T and hepatocellular carcinoma: In HCC, UBE2T exerts oncogenic effects by activating multiple signaling pathways, including AKT/mTOR [81] and Wnt/β-catenin [45], which promote cell proliferation, invasion, migration, and stemness.